三苯氧胺与抗纤维化
Tamoxifen and anti-fibrosis
出处
《中国美容医学》
CAS
2005年第5期649-651,共3页
Chinese Journal of Aesthetic Medicine
参考文献24
-
1Jornon VC.The pharmacology of antiestrogens,In:Rose D Ped,Endocrinology of Cancer [M].vol 3,Boca Rolon,CRC Press Inc,1982:130-173.
-
2Ashcroft GS. Dodsworth J. Van Boxtel Eetal. Estrogen accelerates crtaneous wound healing associated with an increase in TGF-beta levels [J]. Nat Med, 1997, 3(11):1195-1206.
-
3Grow DR, Mikich Y, Coddington C,et al. Role of hypoestrogenism or sex sterdid antagonism in adhesion formation after myometrial surgery in primates [J]. Fertil Steril, 1996, 66(1):140-147.
-
4Soyto T, Ito Y, et al. Hormone regulation of collagenolysis in uterine cervical fibroblasts. Modulation of ythesis of metalloproteinases(TIMP) by progesterone and oestradiol-17beta[J].Biochem J, 1991,275(3):645-650.
-
5Ashcroft GS,Greenwell-Wild T,Horan MA, et al. Topical estrogen accelerates cutaneous wound healing in aged human associated with an altered inflammatory response[J].Am J Pathol, 1999,155(4):1137-1146 .
-
6Hosokawa M,Lshii M,Inoue K, et al. Estrogen induces different respornses in dermal and lung fibroblasts:Special reference to collagen[J].Connect Jissue Res, 1981,9(2): 115.
-
7Bentley JP,Brenner RM,Linsedt AD, et al. Inereased hyaluronate and collagen biosynthesis and fibroblast estrogen receptors in macaquesex skin[J]. J Inves Dermatol,1986, 87(5): 668.
-
8Tanka K,Nakamura T,Takegaki K, et al. Regulation of hyaluronare metabolism by progesterone in cultured fibroblasts from the human uterine cervix[J].FEBS Lett, 1997,402(2-3):223.
-
9Fujimoto J,Hori M,Zchogo S,et al. Ovarian steroid regulate the expression of basic fibroblast growth factor and issm RNA in fibroblasts derived from uterine endometrium [J].Ann Clin Biochem, 1997,34( l ):91.
-
10Kinzbrunner B, Ritter S, Domingo J, et al. Remission of rapidly growing desmoid tumors after tamoxifen therapy [J].Cancer,1983,52 (12) :2201-2204.
二级参考文献4
-
1Chau D,Ann Plast Surg,1998年,40卷,5期,490页
-
2Hu D,Br J Plast Surg,1998年,51卷,6期,462页
-
3Henri Pujol,Jacques Girault,Philippe Rouanet,Sabine Fournier,Jean Grenier,Jo?lle Simony,Jean-Bernard Fourtillan,Jean-Louis Pujol. Phase I Study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissue[J] 1995,Cancer Chemotherapy and Pharmacology(6):493~498
-
4S. Mac Neil,M. Wagner,I. G. Rennie. Investigation of the role of signal transduction in attachment of ocular melanoma cells to matrix proteins: inhibition of attachment by calmodulin antagonists including tamoxifen[J] 1994,Clinical & Experimental Metastasis(6):375~384
共引文献10
-
1窦孝康.雌三醇及拮抗剂三苯氧胺对兔耳瘢痕增生的影响[J].中国生化药物杂志,2014,34(5):29-32. 被引量:1
-
2赵京玉,仇树林.三苯氧胺对兔耳增生性瘢痕形成的影响[J].感染.炎症.修复,2006,7(3):150-152.
-
3王巍,郝立君,王洁,庞建华,刘莺,王辉.他莫昔芬对兔耳增生性瘢痕作用的实验研究[J].黑龙江医学,2005,29(11):821-823. 被引量:1
-
4韩胜,仇树林,彭彦辉,李兵,张培培.他莫昔芬对扩张皮瓣即时回缩率及纤维包膜组织学的影响[J].中国实用美容整形外科杂志,2006,17(2):151-154. 被引量:13
-
5李兵,仇树林,韩胜,张培培.三苯氧胺软膏对增生性瘢痕成纤维细胞影响的研究[J].河北医药,2006,28(8):670-671. 被引量:1
-
6邓长弓,梁越洋.TAM在非乳腺癌领域中的应用[J].四川省卫生管理干部学院学报,2007,26(1):50-52. 被引量:2
-
7赵京玉,柴家科,宋慧锋,韩焱福,许明火,孙天骏,李东杰.他莫昔芬软膏对兔耳增生性瘢痕中TGF-β2 表达的影响[J].中华整形外科杂志,2011,27(3):213-217. 被引量:3
-
8胡大海,陈璧,曹茂开,朱雄翔,徐明达.重组融合饰胶蛋白拮抗转化生长因子β_1刺激增生性瘢痕成纤维细胞增殖的作用[J].中华创伤杂志,2001,17(6):330-333. 被引量:9
-
9史亮亮,刘名倬,江政英,虞小亭,李嘉琪,郭光华.药物干预增生性瘢痕的研究进展[J].中华烧伤与创面修复杂志,2022,38(12):1179-1184. 被引量:4
-
10苏佳.他莫昔芬的临床新用途[J].药学实践杂志,2002,20(6):323-324. 被引量:5
-
1王淑静,刘晨,姜珊,孙希,徐芳,叶展俞,王怡南.苦参碱在肝癌治疗中的研究进展[J].黑龙江医药,2013,26(2):289-290. 被引量:2
-
2段勋伟,郑玉霞,杜绍先.三苯氧胺联合甲状腺片治疗乳腺增生症[J].河南外科学杂志,2008,14(2):88-89. 被引量:3
-
3张惠,徐玉秀,陈星薇,侯秀芬.77例服用三苯氧胺的乳腺癌患者脂肪肝的超声观察[J].北京医学,1999,21(1):51-52. 被引量:1
-
4雷小敏.三苯氧胺和传统的HRT预防心血管的危险因素[J].实用医学进修杂志,1999,27(2):127-127.
-
5熊斌,侯令密.中西药结合治疗乳腺增生症的临床疗效观察[J].按摩与康复医学,2011,2(22):3-4. 被引量:1
-
6宋涛,李辛,胡鸿涛,黎海亮.乳腺癌术后三苯氧胺致脂肪肝36例分析[J].实用医学杂志,2010,26(13):2362-2364. 被引量:12
-
7林勇,陈文彬,程德云.三苯氧胺对低氧性肺动脉高压大鼠平均肺动脉压与IGF-1的影响[J].南京铁道医学院学报,2004,23(6):379-383. 被引量:1
-
8张文发,李爱娇.拜唐苹治疗糖耐量低减患者临床观察[J].江西医药,2002,37(6):444-445. 被引量:2
-
9叶清,李燕芹.组蛋白去乙酰化酶抑制剂的抗纤维化作用[J].国际呼吸杂志,2012,32(12):937-940.
-
10张玉琴.中西医结合治疗乳腺增生症389例临床观察[J].国医论坛,2008,23(4):34-34.